Latest On Syndax Pharmaceuticals, Inc (SNDX):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-09 04:24 EST | News | Syndax Pharmaceuticals GAAP EPS of -$0.59 beats by $0.01 | N/A |  |
| 2023-05-09 04:24 EST | News | Syndax Pharmaceuticals, Inc. (SNDX) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-08 02:38 EST | News | Syndax Pharmaceuticals Q1 2023 Earnings Preview | N/A | |
| 2023-03-04 02:40 EST | News | Syndax Pharmaceuticals, Inc. (SNDX) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-03-01 16:35 EST | News | Syndax Pharmaceuticals: 2023 Is A Pivotal Year | N/A | |
| 2023-03-01 01:25 EST | News | Syndax Pharmaceuticals GAAP EPS of -$0.62 beats by $0.04 | N/A | |
| 2023-02-27 19:50 EST | News | Syndax Pharmaceuticals Q4 2022 Earnings Preview | N/A | |
| 2023-01-12 14:22 EST | News | Syndax Pharmaceuticals (SNDX) Presents at the 41st Annual J.P. Morgan Healthcare Conference -- Slideshow | N/A | |
| 2022-12-17 03:56 EST | News | Syndax Pharmaceuticals (SNDX) Presents at 64th ASH Annual Meeting & Exposition | N/A | |
| 2022-12-12 19:48 EST | News | Kura Oncology falls, Syndax gains after Phase 1/2 data for leukemia candidates | N/A | |
| 2022-12-10 16:27 EST | News | Syndax Pharmaceuticals: Today's Best Nearby Biotech Cap-Gain Prospect | N/A | |
| 2022-12-07 20:58 EST | News | Syndax Pharmaceuticals prices $150M offering | N/A | |
| 2022-12-07 01:27 EST | News | Syndax Pharma to sell $150M stock in public offering | N/A | |
| 2022-12-05 14:27 EST | News | Syndax receives breakthrough therapy tag for revumenib to treat acute leukemia | N/A | |
| 2022-11-06 14:31 EST | News | Syndax Pharmaceuticals, Inc. (SNDX) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-06 14:31 EST | News | Syndax Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call Presentation | N/A | |
| 2022-11-04 08:33 EST | News | Syndax Pharmaceuticals GAAP EPS of -$0.58 beats by $0.07; updates FY22 guidance | N/A | |
| 2022-11-02 23:19 EST | News | Syndax Pharmaceuticals Q3 2022 Earnings Preview | N/A | |
| 2022-08-09 08:07 EST | News | Syndax Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call Presentation | N/A | |
| 2022-08-09 08:07 EST | News | Syndax Pharmaceuticals GAAP EPS of -$0.62 | N/A | |
| 2022-08-09 08:07 EST | News | Syndax Pharmaceuticals, Inc. (SNDX) CEO Michael Metzger on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-08 07:37 EST | News | Syndax Pharmaceuticals Q2 2022 Earnings Preview | N/A | |
| 2022-06-13 12:56 EST | News | Keith Goldan joins Syndax Pharmaceuticals as CFO | N/A | |
| 2022-05-10 14:01 EST | News | Syndax Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call Presentation | N/A | |
| 2022-05-10 14:01 EST | News | Syndax Pharmaceuticals, Inc. (SNDX) CEO Michael Metzger on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-09 16:51 EST | News | Syndax Pharmaceuticals GAAP EPS of -$0.63 | N/A | |
| 2022-05-09 00:26 EST | News | Syndax Pharmaceuticals Q1 2022 Earnings Preview | N/A | |
| 2022-04-08 05:11 EST | News | Syndax Pharmaceuticals: Cash-Rich With 2 Promising Drugs | N/A | |
| 2022-03-25 00:25 EST | News | Syndax Pharmaceuticals (SNDX) Presents At Barclays Global Healthcare Conference | N/A | |
| 2022-03-02 06:49 EST | News | Syndax appoints former Alnylam executive as new medical chief | N/A | |
| 2022-03-02 06:49 EST | News | Syndax Pharmaceuticals GAAP EPS of $1.81 beats by $1.84, revenue of $126.6M beats by $67.92M | N/A | |
| 2022-03-02 06:48 EST | News | Syndax Pharmaceuticals, Inc. (SNDX) CEO Michael Metzger on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-28 18:56 EST | News | Syndax Pharmaceuticals Q4 Earnings Preview | N/A | |
| 2022-01-29 06:36 EST | News | Syndax Pharmaceuticals (SNDX) Investor Presentation - Slideshow | N/A | |
| 2021-12-23 00:22 EST | News | Syndax's SNDX-5613 an Orphan Drug in Europe for acute myeloid leukemia | N/A | |
| 2021-12-16 14:02 EST | News | Syndax Pharma raises $75M via stock offering | N/A | |
| 2021-12-15 18:28 EST | News | Syndax Pharmaceuticals drops 6% following underwritten stock offering | N/A | |
| 2021-11-16 08:01 EST | News | Syndax Pharmaceuticals EPS misses by $0.35, misses on revenue | N/A | |
| 2021-11-16 08:01 EST | News | Syndax Pharmaceuticals, Inc. (SNDX) CEO Briggs Morrison on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-16 08:01 EST | News | Syndax Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call Presentation | N/A | |
| 2021-11-14 18:13 EST | News | Syndax Pharmaceuticals Q3 2021 Earnings Preview | N/A | |
| 2021-11-04 16:35 EST | News | Syndax Pharma falls after updating early-stage data for leukemia therapy | N/A | |
| 2021-10-05 15:59 EST | News | Syndax Pharma CFO Daphne Karydas to resign to pursue another opportunity | N/A | |
| 2021-09-28 02:06 EST | News | Incyte and Syndax in pact for xatilimab targeting immune-related conditions | N/A | |
| 2021-08-10 12:01 EST | News | Syndax Pharmaceuticals EPS beats by $0.28, beats on revenue | N/A | |
| 2021-08-10 12:00 EST | News | Syndax Pharmaceuticals, Inc. (SNDX) CEO Briggs Morrison on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-10 11:59 EST | News | Syndax Pharmaceuticals, Inc. 2021 Q2 - Results - Earnings Call Presentation | N/A | |
| 2021-07-22 02:04 EST | News | Syndax Pharmaceuticals: Updated Analysis After Reporting Interim Phase 1 Data | N/A | |
| 2021-07-22 02:02 EST | News | Canopy upgraded on economy reopening, Xeris PT cut on acquisition news, and more in analyst action | N/A | |
| 2021-07-22 01:35 EST | News | Syndax shares rise on FDA Fast Track status for leukemia treatment SNDX-5613 | N/A | |
About Syndax Pharmaceuticals, Inc (SNDX):
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML); and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD). The company is also developing Entinostat. It also has collaborative research and development agreement with National Cancer Institute; a clinical trial agreement with Eastern Cooperative Oncology Group; and a license agreement with Kyowa Hakko Kirin Co., Ltd. The company was incorporated in 2005 and is headquartered in Waltham, Massachusetts.
General
- Name Syndax Pharmaceuticals, Inc
- Symbol SNDX
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 43
- Fiscal Year EndDecember
- IPO Date2016-03-03
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.syndax.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 634.74
- Price/Book (Most Recent Quarter) 4.43
- Enterprise Value Revenue 542.55
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$2.19
- Next Year EPS Estimate -$2.17
- Next Quarter EPS Estimate -$0.47
- Operating Margin -4708%
- Return on Assets -25%
- Return on Equity -52%
- Revenue 1.52 million
- Earnings Per Share -$2.36
- Revenue Per Share $0.04
- Gross Profit 1.52 million
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 1.16 billion
- EBITDA -67280000
- PE Ratio -125.39
- Analyst Target Price $32.14
- Book Value Per Share $5.27
View More
Share Statistics
- Shares Outstanding 48.24 million
- Shares Float 42.95 million
- % Held by Insiders 645%
- % Held by Institutions 78.88%
- Shares Short 4.93 million
- Shares Short Prior Month 4.93 million
- Short Ratio 9.27
- Short % of Float 11%
- Short % of Shares Outstanding 10%
View More
Technicals
- Beta 1.84
- 52 Week High $27.12
- 52 Week Low $8.18
- 50 Day Moving Average 22.33
- 200 Day Moving Average 20.55
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Syndax Pharmaceuticals, Inc (SNDX) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Syndax Pharmaceuticals, Inc (SNDX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-08 | $380000 | -$0.44 | -$0.51 | 13.23% |
| 2020-09-30 | 2020-11-02 | $N/A | -$0.46 | -$0.43 | -6.75% |
| 2020-06-30 | 2020-08-06 | $N/A | -$0.42 | -$0.44 | 4.76% |
| 2020-03-31 | 2020-05-07 | $379000 | -$0.56 | -$0.53 | -6.65% |
| 2019-12-31 | 2020-03-03 | $380000 | -$0.44 | -$0.43 | -1.31% |
| 2019-09-30 | 2019-11-07 | $379000 | -$0.41 | -$0.48 | 13.92% |
| 2019-06-30 | 2019-08-07 | $379000 | -$0.47 | -$0.47 | 0.76% |
| 2019-03-31 | 2019-05-06 | $379000 | -$0.53 | -$0.55 | 4.14% |
| 2018-12-31 | 2019-03-07 | $379000 | -$0.70 | -$0.64 | -9.43% |
| 2018-09-30 | 2018-11-05 | $379000 | -$0.68 | -$0.76 | 10.21% |
| 2018-06-30 | 2018-08-07 | $379000 | -$0.74 | -$0.89 | 16.94% |
| 2018-03-31 | 2018-05-08 | $379000 | -$0.79 | -$0.95 | 17.15% |
| 2017-12-31 | 2018-03-05 | $1.19 million | -$0.80 | -$0.77 | -3.67% |
| 2017-09-30 | 2017-11-07 | $305000 | -$0.68 | -$0.82 | 16.63% |
| 2017-06-30 | 2017-08-10 | $305000 | -$0.70 | -$0.82 | 14.83% |
| 2017-03-31 | 2017-05-08 | $305000 | -$0.71 | -$0.71 | 0.56% |
| 2016-12-31 | 2017-03-02 | $305000 | -$0.59 | -$0.74 | 19.79% |
| 2016-09-30 | 2016-11-10 | $305000 | -$0.84 | -$0.82 | -2.78% |
| 2016-06-30 | 2016-08-09 | $305000 | -$0.47 | -$0.54 | 12.18% |
| 2016-03-31 | 2016-05-16 | $305000 | -$0.73 | -$0.48 | -52.22% |
Syndax Pharmaceuticals, Inc (SNDX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Syndax Pharmaceuticals, Inc (SNDX) Chart:
Syndax Pharmaceuticals, Inc (SNDX) News:
Below you will find a list of latest news for Syndax Pharmaceuticals, Inc (SNDX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Syndax Pharmaceuticals, Inc (SNDX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-21 | 2.5 | 0 | CALL | 0 | 0 | 904.3 | TRUE | 0 | 0 |
| 2025-03-21 | 5 | 11.1 | CALL | 0 | 15 | 526.54 | TRUE | 0 | 0 |
| 2025-03-21 | 7.5 | 0 | CALL | 0 | 0 | 363.85 | TRUE | 0 | 0 |
| 2025-03-21 | 10 | 0 | CALL | 0 | 0 | 267.31 | TRUE | 0 | 0 |
| 2025-03-21 | 12.5 | 2.9 | CALL | 0 | 2 | 93.67 | TRUE | 0 | 0 |
| 2025-03-21 | 15 | 1.7 | CALL | 211 | 6492 | 63.45 | TRUE | 1.7 | 0 |
| 2025-03-21 | 17.5 | 0.6 | CALL | 1075 | 4910 | 63.26 | FALSE | 0.6 | 0 |
| 2025-03-21 | 20 | 0 | CALL | 0 | 0 | 73.79 | FALSE | 0 | 0 |
| 2025-03-21 | 22.5 | 0 | CALL | 0 | 0 | 125.44 | FALSE | 0 | 0 |
| 2025-03-21 | 25 | 0 | CALL | 0 | 0 | 139.23 | FALSE | 0 | 0 |
| 2025-03-21 | 2.5 | 0 | PUT | 0 | 0 | 597.18 | FALSE | 0 | 0 |
| 2025-03-21 | 5 | 0 | PUT | 0 | 0 | 402.93 | FALSE | 0 | 0 |
| 2025-03-21 | 7.5 | 0 | PUT | 0 | 0 | 264.37 | FALSE | 0 | 0 |
| 2025-03-21 | 10 | 0 | PUT | 0 | 0 | 191.47 | FALSE | 0 | 0 |
| 2025-03-21 | 12.5 | 0.36 | PUT | 0 | 2 | 83.98 | FALSE | 0 | 0 |
| 2025-03-21 | 15 | 1.8 | PUT | 0 | 308 | 64.34 | FALSE | 0 | 0 |
| 2025-03-21 | 17.5 | 2.95 | PUT | 15 | 1 | 114.49 | TRUE | 2.95 | 0 |
| 2025-03-21 | 20 | 0 | PUT | 0 | 0 | 174.24 | TRUE | 0 | 0 |
| 2025-03-21 | 22.5 | 0 | PUT | 0 | 0 | 136.46 | TRUE | 0 | 0 |
| 2025-03-21 | 25 | 0 | PUT | 0 | 0 | 120.19 | TRUE | 0 | 0 |
| 2025-04-17 | 2.5 | 0 | CALL | 0 | 0 | 650.04 | TRUE | 0 | 0 |
| 2025-04-17 | 5 | 0 | CALL | 0 | 0 | 377.82 | TRUE | 0 | 0 |
| 2025-04-17 | 7.5 | 0 | CALL | 0 | 0 | 260.56 | TRUE | 0 | 0 |
| 2025-04-17 | 10 | 4 | CALL | 0 | 2 | 97.59 | TRUE | 0 | 0 |
| 2025-04-17 | 12.5 | 2.41 | CALL | 0 | 37 | 80.39 | TRUE | 0 | 0 |
| 2025-04-17 | 15 | 2.25 | CALL | 0 | 527 | 40.89 | TRUE | 0 | 0 |
| 2025-04-17 | 17.5 | 0.75 | CALL | 0 | 371 | 56.43 | FALSE | 0 | 0 |
| 2025-04-17 | 20 | 0.4 | CALL | 1 | 214 | 59.94 | FALSE | 0.4 | 0 |
| 2025-04-17 | 22.5 | 0.2 | CALL | 5 | 60 | 64.1 | FALSE | 0.2 | 0 |
| 2025-04-17 | 25 | 0.19 | CALL | 0 | 16 | 101.25 | FALSE | 0 | 0 |
| 2025-04-17 | 30 | 0.05 | CALL | 0 | 84 | 104.88 | FALSE | 0 | 0 |
| 2025-04-17 | 35 | 2.7 | CALL | 0 | 1 | 240.76 | FALSE | 0 | 0 |
| 2025-04-17 | 40 | 0 | CALL | 0 | 0 | 259.57 | FALSE | 0 | 0 |
| 2025-04-17 | 2.5 | 0 | PUT | 0 | 0 | 540.86 | FALSE | 0 | 0 |
| 2025-04-17 | 5 | 0 | PUT | 0 | 0 | 252.77 | FALSE | 0 | 0 |
| 2025-04-17 | 7.5 | 0 | PUT | 0 | 0 | 350.22 | FALSE | 0 | 0 |
| 2025-04-17 | 10 | 0 | PUT | 0 | 0 | 120.05 | FALSE | 0 | 0 |
| 2025-04-17 | 12.5 | 0.7 | PUT | 0 | 2101 | 171.29 | FALSE | 0 | 0 |
| 2025-04-17 | 15 | 1.35 | PUT | 0 | 245 | 119.44 | FALSE | 0 | 0 |
| 2025-04-17 | 17.5 | 4.4 | PUT | 0 | 85 | 18.86 | TRUE | 0 | 0 |
| 2025-04-17 | 20 | 4.8 | PUT | 0 | 59 | 79.83 | TRUE | 0 | 0 |
| 2025-04-17 | 22.5 | 6.35 | PUT | 0 | 11 | 107.82 | TRUE | 0 | 0 |
| 2025-04-17 | 25 | 9.9 | PUT | 0 | 0 | 112.05 | TRUE | 0 | 0 |
| 2025-04-17 | 30 | 14 | PUT | 0 | 0 | 91.75 | TRUE | 0 | 0 |
| 2025-04-17 | 35 | 0 | PUT | 0 | 0 | 142.97 | TRUE | 0 | 0 |
| 2025-04-17 | 40 | 0 | PUT | 0 | 0 | 212.45 | TRUE | 0 | 0 |
| 2025-07-18 | 2.5 | 0 | CALL | 0 | 0 | 398.39 | TRUE | 0 | 0 |
| 2025-07-18 | 5 | 9.9 | CALL | 0 | 1 | 222.1 | TRUE | 0 | 0 |
| 2025-07-18 | 7.5 | 0 | CALL | 0 | 0 | 168.59 | TRUE | 0 | 0 |
| 2025-07-18 | 10 | 0 | CALL | 0 | 0 | 88.32 | TRUE | 0 | 0 |
| 2025-07-18 | 12.5 | 4.42 | CALL | 0 | 306 | 64.39 | TRUE | 0 | 0 |
| 2025-07-18 | 15 | 2.9 | CALL | 10 | 519 | 57.18 | TRUE | 2.9 | 0 |
| 2025-07-18 | 17.5 | 1.85 | CALL | 454 | 489 | 62.32 | FALSE | 0.3 | 0.19 |
| 2025-07-18 | 20 | 1.16 | CALL | 6 | 471 | 57.72 | FALSE | 0.31 | 0.36 |
| 2025-07-18 | 22.5 | 0.42 | CALL | 0 | 5 | 58.95 | FALSE | 0 | 0 |
| 2025-07-18 | 25 | 0.7 | CALL | 0 | 1 | 84.94 | FALSE | 0 | 0 |
| 2025-07-18 | 30 | 0.25 | CALL | 0 | 2 | 57.18 | FALSE | 0 | 0 |
| 2025-07-18 | 2.5 | 0 | PUT | 0 | 0 | 249.57 | FALSE | 0 | 0 |
| 2025-07-18 | 5 | 0 | PUT | 0 | 0 | 203.6 | FALSE | 0 | 0 |
| 2025-07-18 | 7.5 | 0 | PUT | 0 | 0 | 217.49 | FALSE | 0 | 0 |
| 2025-07-18 | 10 | 0 | PUT | 0 | 0 | 108.79 | FALSE | 0 | 0 |
| 2025-07-18 | 12.5 | 0.9 | PUT | 0 | 301 | 69.59 | FALSE | 0 | 0 |
| 2025-07-18 | 15 | 2.35 | PUT | 0 | 319 | 62.74 | FALSE | 0 | 0 |
| 2025-07-18 | 17.5 | 3.4 | PUT | 1 | 323 | 64.98 | TRUE | 3.4 | 0 |
| 2025-07-18 | 20 | 7.73 | PUT | 0 | 18 | 48.1 | TRUE | 0 | 0 |
| 2025-07-18 | 22.5 | 0 | PUT | 0 | 0 | 64.32 | TRUE | 0 | 0 |
| 2025-07-18 | 25 | 0 | PUT | 0 | 0 | 76.98 | TRUE | 0 | 0 |
| 2025-07-18 | 30 | 16.5 | PUT | 0 | 0 | 93.22 | TRUE | 0 | 0 |
| 2025-10-17 | 2.5 | 0 | CALL | 0 | 0 | 327.32 | TRUE | 0 | 0 |
| 2025-10-17 | 5 | 0 | CALL | 0 | 0 | 192.09 | TRUE | 0 | 0 |
| 2025-10-17 | 7.5 | 0 | CALL | 0 | 0 | 139.32 | TRUE | 0 | 0 |
| 2025-10-17 | 10 | 0 | CALL | 0 | 0 | 37.56 | TRUE | 0 | 0 |
| 2025-10-17 | 12.5 | 0 | CALL | 0 | 0 | 61.93 | TRUE | 0 | 0 |
| 2025-10-17 | 15 | 0 | CALL | 0 | 0 | 71.99 | TRUE | 0 | 0 |
| 2025-10-17 | 17.5 | 3 | CALL | 40 | 0 | 66.26 | FALSE | 3 | 0 |
| 2025-10-17 | 20 | 0 | CALL | 0 | 0 | 60.24 | FALSE | 0 | 0 |
| 2025-10-17 | 22.5 | 0 | CALL | 0 | 0 | 58.95 | FALSE | 0 | 0 |
| 2025-10-17 | 25 | 0 | CALL | 0 | 0 | 63.75 | FALSE | 0 | 0 |
| 2025-10-17 | 30 | 0 | CALL | 0 | 0 | 81.37 | FALSE | 0 | 0 |
| 2025-10-17 | 2.5 | 0 | PUT | 0 | 0 | 638.72 | FALSE | 0 | 0 |
| 2025-10-17 | 5 | 0 | PUT | 0 | 0 | 252.49 | FALSE | 0 | 0 |
| 2025-10-17 | 7.5 | 0 | PUT | 0 | 0 | 93.01 | FALSE | 0 | 0 |
| 2025-10-17 | 10 | 0 | PUT | 0 | 0 | 77.24 | FALSE | 0 | 0 |
| 2025-10-17 | 12.5 | 0 | PUT | 0 | 0 | 84.43 | FALSE | 0 | 0 |
| 2025-10-17 | 15 | 0 | PUT | 0 | 0 | 63.97 | FALSE | 0 | 0 |
| 2025-10-17 | 17.5 | 0 | PUT | 0 | 0 | 56.82 | TRUE | 0 | 0 |
| 2025-10-17 | 20 | 0 | PUT | 0 | 0 | 66.12 | TRUE | 0 | 0 |
| 2025-10-17 | 22.5 | 0 | PUT | 0 | 0 | 65.63 | TRUE | 0 | 0 |
| 2025-10-17 | 25 | 0 | PUT | 0 | 0 | 61.24 | TRUE | 0 | 0 |
| 2025-10-17 | 30 | 0 | PUT | 0 | 0 | 79.91 | TRUE | 0 | 0 |
| 2026-01-16 | 2.5 | 20.5 | CALL | 0 | 1 | 277.62 | TRUE | 0 | 0 |
| 2026-01-16 | 5 | 0 | CALL | 0 | 0 | 162.04 | TRUE | 0 | 0 |
| 2026-01-16 | 7.5 | 8.65 | CALL | 0 | 23 | 113.23 | TRUE | 0 | 0 |
| 2026-01-16 | 10 | 7.05 | CALL | 0 | 74 | 67.03 | TRUE | 0 | 0 |
| 2026-01-16 | 12.5 | 5 | CALL | 0 | 32 | 62.19 | TRUE | 0 | 0 |
| 2026-01-16 | 15 | 4.3 | CALL | 11 | 32 | 60.88 | TRUE | 4.3 | 0 |
| 2026-01-16 | 17.5 | 2.82 | CALL | 0 | 590 | 62.86 | FALSE | 0 | 0 |
| 2026-01-16 | 20 | 2.3 | CALL | 1 | 495 | 62.34 | FALSE | 2.3 | 0 |
| 2026-01-16 | 22.5 | 1.55 | CALL | 0 | 58 | 46.2 | FALSE | 0 | 0 |
| 2026-01-16 | 25 | 1.45 | CALL | 0 | 48 | 61.83 | FALSE | 0 | 0 |
| 2026-01-16 | 30 | 0.99 | CALL | 0 | 25 | 57.63 | FALSE | 0 | 0 |
| 2026-01-16 | 35 | 0.5 | CALL | 0 | 8 | 54.58 | FALSE | 0 | 0 |
| 2026-01-16 | 2.5 | 0 | PUT | 0 | 0 | 128.69 | FALSE | 0 | 0 |
| 2026-01-16 | 5 | 0.41 | PUT | 0 | 5 | 108.25 | FALSE | 0 | 0 |
| 2026-01-16 | 7.5 | 0 | PUT | 0 | 0 | 99.61 | FALSE | 0 | 0 |
| 2026-01-16 | 10 | 1.17 | PUT | 0 | 5 | 65.85 | FALSE | 0 | 0 |
| 2026-01-16 | 12.5 | 2.28 | PUT | 0 | 4 | 49.05 | FALSE | 0 | 0 |
| 2026-01-16 | 15 | 2.95 | PUT | 12 | 8 | 63.89 | FALSE | 2.95 | 0 |
| 2026-01-16 | 17.5 | 5.3 | PUT | 0 | 4 | 61.56 | TRUE | 0 | 0 |
| 2026-01-16 | 20 | 0 | PUT | 0 | 0 | 52.98 | TRUE | 0 | 0 |
| 2026-01-16 | 22.5 | 5.1 | PUT | 0 | 6 | 65 | TRUE | 0 | 0 |
| 2026-01-16 | 25 | 0 | PUT | 0 | 0 | 64.5 | TRUE | 0 | 0 |
| 2026-01-16 | 30 | 0 | PUT | 0 | 0 | 75.16 | TRUE | 0 | 0 |
| 2026-01-16 | 35 | 0 | PUT | 0 | 0 | 83.84 | TRUE | 0 | 0 |
Latest SNDX Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 3 | $15.6 |
| Jun 13, 2022 7:59 PM EST | 4 | $15.6 |
| Jun 13, 2022 7:59 PM EST | 1 | $15.6 |
| Jun 13, 2022 7:59 PM EST | 100 | $15.61 |
| Jun 13, 2022 7:59 PM EST | 45 | $15.61 |
Syndax Pharmaceuticals, Inc (SNDX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000156459020028764/0001564590-20-028764-index.htm |
| 2019-09-05 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1395937/000000000019013216/0000000000-19-013216-index.htm |
| 2019-02-08 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1395937/000021545719006549/0000215457-19-006549-index.htm |
| 2020-02-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1395937/000083423720006818/0000834237-20-006818-index.htm |
| 2020-09-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1395937/000083423720010194/0000834237-20-010194-index.htm |
| 2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1395937/000090221919000254/0000902219-19-000254-index.htm |
| 2020-01-28 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1395937/000090221920000308/0000902219-20-000308-index.htm |
| 2019-04-08 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1395937/000090266419001816/0000902664-19-001816-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1395937/000090266420000971/0000902664-20-000971-index.htm |
| 2020-11-04 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1395937/000091957420006675/0000919574-20-006675-index.htm |
| 2018-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000092189518001976/0000921895-18-001976-index.htm |
| 2018-11-29 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1395937/000092189518003173/0000921895-18-003173-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1395937/000092189519000467/0000921895-19-000467-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1395937/000092189520000574/0000921895-20-000574-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1395937/000101359419000160/0001013594-19-000160-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1395937/000101359420000127/0001013594-20-000127-index.htm |
| 2018-04-10 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1395937/000114036118018005/0001140361-18-018005-index.htm |
| 2018-04-10 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1395937/000114036118018007/0001140361-18-018007-index.htm |
| 2018-06-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000119312518197997/0001193125-18-197997-index.htm |
| 2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1395937/000119312519034379/0001193125-19-034379-index.htm |
| 2019-03-28 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1395937/000119312519088951/0001193125-19-088951-index.htm |
| 2019-03-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000119312519092679/0001193125-19-092679-index.htm |
| 2019-03-29 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1395937/000119312519092701/0001193125-19-092701-index.htm |
| 2019-08-30 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1395937/000119312519235283/0001193125-19-235283-index.htm |
| 2019-09-06 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1395937/000119312519239953/0001193125-19-239953-index.htm |
| 2019-09-10 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1395937/000119312519242045/0001193125-19-242045-index.htm |
| 2019-10-09 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1395937/000119312519265254/0001193125-19-265254-index.htm |
| 2020-02-03 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1395937/000119312520022917/0001193125-20-022917-index.htm |
| 2020-02-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000119312520023646/0001193125-20-023646-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1395937/000119312520037637/0001193125-20-037637-index.htm |
| 2020-05-11 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1395937/000119312520139263/0001193125-20-139263-index.htm |
| 2018-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218018001800/0001562180-18-001800-index.htm |
| 2018-05-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218018002680/0001562180-18-002680-index.htm |
| 2018-05-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218018002681/0001562180-18-002681-index.htm |
| 2018-05-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218018002682/0001562180-18-002682-index.htm |
| 2018-05-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218018002683/0001562180-18-002683-index.htm |
| 2018-05-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218018002684/0001562180-18-002684-index.htm |
| 2018-05-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218018002685/0001562180-18-002685-index.htm |
| 2018-09-27 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218018004047/0001562180-18-004047-index.htm |
| 2018-09-27 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218018004048/0001562180-18-004048-index.htm |
| 2018-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218018004049/0001562180-18-004049-index.htm |
| 2018-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218018004050/0001562180-18-004050-index.htm |
| 2018-11-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218018004443/0001562180-18-004443-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218019000852/0001562180-19-000852-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218019000853/0001562180-19-000853-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218019000854/0001562180-19-000854-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218019000855/0001562180-19-000855-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218019000856/0001562180-19-000856-index.htm |
| 2019-03-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218019002012/0001562180-19-002012-index.htm |
| 2019-03-25 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218019002023/0001562180-19-002023-index.htm |
| 2019-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218019002780/0001562180-19-002780-index.htm |
| 2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218019003487/0001562180-19-003487-index.htm |
| 2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218019003488/0001562180-19-003488-index.htm |
| 2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218019003489/0001562180-19-003489-index.htm |
| 2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218019003490/0001562180-19-003490-index.htm |
| 2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218019003491/0001562180-19-003491-index.htm |
| 2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218019003492/0001562180-19-003492-index.htm |
| 2019-07-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218019003880/0001562180-19-003880-index.htm |
| 2019-10-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218019005140/0001562180-19-005140-index.htm |
| 2020-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218020000891/0001562180-20-000891-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218020001228/0001562180-20-001228-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218020001229/0001562180-20-001229-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218020001230/0001562180-20-001230-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218020001231/0001562180-20-001231-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218020001232/0001562180-20-001232-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218020001233/0001562180-20-001233-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218020001234/0001562180-20-001234-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218020001235/0001562180-20-001235-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218020001236/0001562180-20-001236-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218020001237/0001562180-20-001237-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218020001238/0001562180-20-001238-index.htm |
| 2020-07-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218020005074/0001562180-20-005074-index.htm |
| 2020-07-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218020005102/0001562180-20-005102-index.htm |
| 2020-11-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1395937/000156218020006583/0001562180-20-006583-index.htm |
| 2018-03-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000156459018004520/0001564590-18-004520-index.htm |
| 2018-03-08 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1395937/000156459018004911/0001564590-18-004911-index.htm |
| 2018-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000156459018011784/0001564590-18-011784-index.htm |
| 2018-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1395937/000156459018012378/0001564590-18-012378-index.htm |
| 2018-05-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000156459018014349/0001564590-18-014349-index.htm |
| 2018-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000156459018019907/0001564590-18-019907-index.htm |
| 2018-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1395937/000156459018020483/0001564590-18-020483-index.htm |
| 2018-08-08 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1395937/000156459018020504/0001564590-18-020504-index.htm |
| 2018-09-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000156459018023593/0001564590-18-023593-index.htm |
| 2018-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000156459018026817/0001564590-18-026817-index.htm |
| 2018-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1395937/000156459018026892/0001564590-18-026892-index.htm |
| 2019-02-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000156459019002676/0001564590-19-002676-index.htm |
| 2019-03-07 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1395937/000156459019006772/0001564590-19-006772-index.htm |
| 2019-03-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000156459019006777/0001564590-19-006777-index.htm |
| 2019-03-18 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1395937/000156459019008313/0001564590-19-008313-index.htm |
| 2019-04-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1395937/000156459019014263/0001564590-19-014263-index.htm |
| 2019-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000156459019015972/0001564590-19-015972-index.htm |
| 2019-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1395937/000156459019017318/0001564590-19-017318-index.htm |
| 2019-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000156459019022241/0001564590-19-022241-index.htm |
| 2019-07-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000156459019024625/0001564590-19-024625-index.htm |
| 2019-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000156459019030050/0001564590-19-030050-index.htm |
| 2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1395937/000156459019030067/0001564590-19-030067-index.htm |
| 2019-08-07 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1395937/000156459019030084/0001564590-19-030084-index.htm |
| 2019-10-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000156459019036518/0001564590-19-036518-index.htm |
| 2019-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000156459019041712/0001564590-19-041712-index.htm |
| 2019-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1395937/000156459019041719/0001564590-19-041719-index.htm |
| 2019-12-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000156459019045581/0001564590-19-045581-index.htm |
| 2020-02-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000156459020004037/0001564590-20-004037-index.htm |
| 2020-02-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000156459020005551/0001564590-20-005551-index.htm |
| 2020-03-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000156459020008426/0001564590-20-008426-index.htm |
| 2020-03-05 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1395937/000156459020009016/0001564590-20-009016-index.htm |
| 2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1395937/000156459020019694/0001564590-20-019694-index.htm |
| 2020-04-30 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1395937/000156459020019928/0001564590-20-019928-index.htm |
| 2020-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000156459020019941/0001564590-20-019941-index.htm |
| 2020-05-04 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1395937/000156459020020574/0001564590-20-020574-index.htm |
| 2020-05-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000156459020020633/0001564590-20-020633-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000156459020022849/0001564590-20-022849-index.htm |
| 2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1395937/000156459020022971/0001564590-20-022971-index.htm |
| 2020-06-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000156459020028764/0001564590-20-028764-index.htm |
| 2020-07-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000156459020031882/0001564590-20-031882-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000156459020037719/0001564590-20-037719-index.htm |
| 2020-08-06 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1395937/000156459020037767/0001564590-20-037767-index.htm |
| 2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1395937/000156459020037777/0001564590-20-037777-index.htm |
| 2020-11-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1395937/000156459020049638/0001564590-20-049638-index.htm |
| 2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1395937/000156459020051287/0001564590-20-051287-index.htm |
| 2019-09-10 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1395937/999999999519002056/9999999995-19-002056-index.htm |
| 2018-11-27 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1395937/999999999716026189/9999999997-16-026189-index.htm |
| 2018-04-03 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1395937/999999999718004150/9999999997-18-004150-index.htm |
| 2018-06-13 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1395937/999999999718006372/9999999997-18-006372-index.htm |
| 2018-08-29 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1395937/999999999718007508/9999999997-18-007508-index.htm |
| 2018-12-20 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1395937/999999999718009113/9999999997-18-009113-index.htm |
| 2019-03-28 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1395937/999999999719002097/9999999997-19-002097-index.htm |
Syndax Pharmaceuticals, Inc (SNDX) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Syndax Pharmaceuticals, Inc (SNDX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 645%Institutional Ownership: 7888%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2018-04-03 | Peter Ordentlich | Chief Scientific Officer | Sell | 7,500.00 | 15.00 | 112,500.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1395937/000156218018001800/0001562180-18-001800-index.htm |
| 2020-07-06 | Michael L. Meyers | SVP, Chief Medical Officer | Buy | 3,500.00 | 10,730.00 | https://www.sec.gov/Archives/edgar/data/1395937/000156218020005074/0001562180-20-005074-index.htm | ||
| 2020-11-04 | Michael A Metzger | President and COO | Buy | 100,000.00 | 7.20 | 720,000.00 | 117,659.00 | https://www.sec.gov/Archives/edgar/data/1395937/000156218020006583/0001562180-20-006583-index.htm |
| 2019-05-09 | Briggs Morrison | Chief Executive Officer | Buy | 13,200.00 | 7.56 | 99,726.00 | 13,200.00 | https://www.sec.gov/Archives/edgar/data/1395937/000156218019002780/0001562180-19-002780-index.htm |
| 2020-02-12 | Michael A Metzger | President and COO | Buy | 15,000.00 | 17,659.00 | https://www.sec.gov/Archives/edgar/data/1395937/000156218020001238/0001562180-20-001238-index.htm | ||
| 2020-11-04 | Michael A Metzger | President and COO | Sell | 100,000.00 | 20.31 | 2,031,410.00 | 17,659.00 | https://www.sec.gov/Archives/edgar/data/1395937/000156218020006583/0001562180-20-006583-index.htm |
| 2019-05-13 | Briggs Morrison | Chief Executive Officer | Buy | 7,200.00 | 7.29 | 52,516.80 | 20,400.00 | https://www.sec.gov/Archives/edgar/data/1395937/000156218019002780/0001562180-19-002780-index.htm |
| 2018-10-30 | Michael L. Meyers | SVP, Chief Medical Officer | Buy | 200.00 | 4.79 | 958.00 | 2,398.00 | https://www.sec.gov/Archives/edgar/data/1395937/000156218018004443/0001562180-18-004443-index.htm |
| 2019-10-10 | Briggs Morrison | Chief Executive Officer | Buy | 11,000.00 | 5.40 | 59,400.00 | 31,400.00 | https://www.sec.gov/Archives/edgar/data/1395937/000156218019005140/0001562180-19-005140-index.htm |
| 2020-02-04 | Briggs Morrison | Chief Executive Officer | Buy | 12,500.00 | 8.00 | 100,000.00 | 43,900.00 | https://www.sec.gov/Archives/edgar/data/1395937/000156218020000891/0001562180-20-000891-index.htm |
| 2019-03-21 | Michael L. Meyers | SVP, Chief Medical Officer | Buy | 1,000.00 | 4.93 | 4,930.00 | 7,118.00 | https://www.sec.gov/Archives/edgar/data/1395937/000156218019002012/0001562180-19-002012-index.htm |
| 2019-03-21 | Michael L. Meyers | SVP, Chief Medical Officer | Buy | 104.00 | 4.87 | 506.48 | 7,222.00 | https://www.sec.gov/Archives/edgar/data/1395937/000156218019002012/0001562180-19-002012-index.htm |
| 2018-04-03 | Peter Ordentlich | Chief Scientific Officer | Buy | 7,500.00 | 3.08 | 23,100.00 | 7,500.00 | https://www.sec.gov/Archives/edgar/data/1395937/000156218018001800/0001562180-18-001800-index.htm |